article
This common vitamin could help fight one of the deadliest brain cancers
Automatically curated summary from ScienceDaily — Mind & Brain.
High-dose vitamin B3 (niacin) shows early promise when combined with standard glioblastoma treatments. In a small trial reported by ScienceDaily, 82% of patients remained progression-free after six months. Researchers hypothesize that niacin helps reactivate immune cells suppressed by this deadly brain cancer. However, scientists emphasize that larger clinical studies are necessary to fully confirm both the therapeutic benefits and safety of this approach.
Context and limitations
The findings are based on a small preliminary trial; larger studies are still required to confirm safety and therapeutic effectiveness.
